| 标题 |
Ifebemtinib plus garsorasib as first-line treatment for KRAS(G12C)-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Respiratory medicine 作者:Song Z; Li X; Lin R; Shi H; Yuan Y; et al 出版日期:2026/07/07 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)